Jensen G, Trautner F, Rasmussen S, Hesse B
Eur J Clin Pharmacol. 1983;24(2):169-72. doi: 10.1007/BF00613812.
The effect of isosorbide-dinitrate (ISDN) 20 mg 4 times daily against placebo has been tested in 12 patients with stable effort induced angina pectoris receiving prophylactic treatment with metoprolol. ISDN did not decrease the attack rate or nitroglycerine consumption, nor was exercise tolerance increased after it. Left ventricular function, assessed by radionuclide ventriculography, increased in 6 out of 8 patients (p less than 0.1). It is concluded that ISDN has no place in the treatment of haemodynamically intact patients with severe angina pectoris in spite of beta-blocking treatment, but that it may be of value in the treatment of patients with left ventricular failure, including those whose left ventricular failure has been brought about by beta-blocking treatment necessitated by angina pectoris.
已对12例接受美托洛尔预防性治疗的稳定型劳力性心绞痛患者进行了试验,比较每日4次服用20毫克硝酸异山梨酯(ISDN)与服用安慰剂的效果。ISDN并未降低发作率或硝酸甘油消耗量,服用后运动耐量也未增加。通过放射性核素心室造影评估,8例患者中有6例左心室功能增强(p小于0.1)。得出的结论是,尽管进行了β受体阻滞剂治疗,但ISDN在治疗血流动力学正常的严重心绞痛患者中并无作用,不过它可能对治疗左心室衰竭患者有价值,包括那些因心绞痛而需要β受体阻滞剂治疗导致左心室衰竭的患者。